SCHEMBL7816643

SCHEMBL7816643

Cc1nc2ccc(-c3ccc4c(c3)CN(c3ncnc5c(Br)cc(Br)cc35)CCO4)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 11/20 0.47
LMNA P02545 5/20 0.41
HTT P42858 5/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
PRNP P04156 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
PPARG P37231 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NR2E3 Q9Y5X4 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C19 P33261 3/20 0.35
HIF1A Q16665 2/20 0.35
CYP3A4 P08684 2/20 0.35
USP2 O75604 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856354 0.94 PIK3CA (0.47) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL861229 0.90 PIK3CA (0.47) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL3764793 0.89 PIK3CA (0.49) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL7823835 0.87 PIK3CA (0.48) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL861601 0.87 PIK3CA (0.48) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL7860271 0.86 PIK3CA (0.47) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL857836 0.86 PIK3CA (0.45) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL855583 0.86 PIK3CA (0.49) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL856295 0.85 PIK3CA (0.47) PIK3CALMNAHTTMAPTNPSR1
SCHEMBL857187 0.85 PIK3CA (0.51) PIK3CALMNAHTTMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010135568-A1 BENZOXAZEPINES AS INHIBITORS OF MTOR AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-11-25 WO disclosed